MiniMed Group: Medtronic ownership falls to zero

The amendment records zero beneficial ownership and voting or dispositive power after the exchange offer.

Rhea-AI Filing Summary

MiniMed Group, Inc. was separated from Medtronic plc on October 15, 2026, through a split-off exchange offer. Medtronic exchanged MiniMed common stock representing approximately 90% of outstanding common stock for Medtronic ordinary shares held by Medtronic shareholders. Medtronic then ceased to own MiniMed common stock. The amended ownership report records 0 shares beneficially owned (0.0%) and zero sole or shared voting and dispositive power.

Key Figures

Common stock exchanged: Approximately 90% Shares beneficially owned: 0 shares Percent of class: 0.0%

3 metrics

Common stock exchanged Approximately 90% Of MiniMed common stock outstanding in the exchange offer completed October 15, 2026

Shares beneficially owned 0 shares Medtronic's amended ownership report

Percent of class 0.0% Medtronic's amended ownership report

Key Terms

split-off exchange offer, beneficially owned, Sole Voting Power, Shared Dispositive Power

4 terms

split-off exchange offer financial

"through a split-off exchange offer"

beneficially owned financial

"Amount beneficially owned: 0"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"Sole Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Shared Dispositive Power financial

"Shared Dispositive Power 0.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MMED shares does Medtronic own?

Medtronic reported 0 MiniMed shares beneficially owned, or 0.0%. It also reported zero sole and shared voting power and zero sole and shared dispositive power.

What happened in MiniMed's separation from Medtronic?

On October 15, 2026, Medtronic completed a split-off exchange offer, exchanging MiniMed common stock representing approximately 90% of outstanding common stock for Medtronic ordinary shares held by Medtronic shareholders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/16/2026 - 04:21 PM EDT Accepted by SEC EDGAR 10/16/2026 - 04:21 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

MiniMed Group, Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

60365F109

(CUSIP Number)

10/15/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 60365F109

1

Names of Reporting Persons

Medtronic plc

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

IRELAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

FI

Comment for Type of Reporting Person: On October 15, 2026, Medtronic plc ("Medtronic") completed the separation of MiniMed Group, Inc. (the "Issuer") through a split-off exchange offer (the "Exchange Offer"), pursuant to which Medtronic exchanged shares of common stock, par value $0.01 per share (the "Common Stock"), of the Issuer representing approximately 90% of shares of outstanding Common Stock for outstanding ordinary shares of Medtronic held by Medtronic shareholders. As a result of the Exchange Offer, Medtronic ceased to own any shares of Common Stock of the Issuer. This Amendment No. 1 to the Schedule 13G is being filed to reflect the fact that Medtronic no longer holds more than 5% of the Common Stock of the Issuer, and has ceased to be a Schedule 13G reporting person with regard to the Common Stock.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MiniMed Group, Inc.
(b)	Address of issuer's principal executive offices: 18000 Devonshire Street, Northridge, CA 91325
Item 2.
(a)	Name of person filing: Medtronic plc
(b)	Address or principal business office or, if none, residence: Building Two, Parkmore Business Park West, Galway, Ireland H91 4K49
(c)	Citizenship: L2
(d)	Title of class of securities: Common Stock, par value $0.01 per share
(e)	CUSIP No.: 60365F109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0.0%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Medtronic plc

Signature:	/s/ Brian Sandstrom
Name/Title:	Brian Sandstrom/VP, Chief Corporate and Securities Counsel
Date:	10/16/2026